This may be because:
- You've already used a FreeStyle Libre 3 Plus sensor or redeemed this offer.
- Free♢ sensors aren't offered in your state.
- For compliance reasons, we are not able to offer free♢ sensors for your insurance type.
What's next?
You may still be able to get the Libre 3 Plus sensor through your insurance. Talk to your doctor about getting a prescription. Our doctor discussion guide can help you prepare for that conversation.
Find out if Libre systems are covered by your insurance.
Private insurance
Most covered patients pay $0–$20 for Libre sensors***1.
Libre systems are covered by over 95% of private insurance plans1.
Medicare
Libre systems are widely covered for people managing diabetes with insulin†††1,2 and people with problematic hypoglycemia (or low sugar levels)†‡‡‡2.
Most people on Medicare Advantage/Managed Medicare pay $0 for Libre§§§1.
Medicad
Medicaid, which helps people with limited income cover health costs, may cover Libre systems.
Many states offer coverage for Libre systems under Medicaid, and may require prior authorization (PA) from your healthcare provider.
Veterans Affairs (VA) /TRICARE
People who are veterans, or in military families, may get Libre systems through VA or TRICARE.
Libre systems are covered by the Department of Veterans Affairs and Department of Defense TRICARE for those who qualify1,3–5, and may require prior authorization (PA) from your healthcare provider.
Uninsured
The final cost depends on your insurance plan, but if you are commercially insured or uninsured and asked to pay over $75 for two sensors, please use our Copay Card to start saving immediately¶.
Cost & Coverage questions? Please contact our Customer Care Team.
Contact Customer Care Team
Chat with us, available 24/7; excluding holidays.
Call us at 1-855-632-8658, available 7 days a week, 8 AM to 8 PM Eastern Time; excluding holidays.
Have questions? We have answers!
Please contact a participating pharmacy‡ or supplier‡ for more information about out-of-pocket costs. Please note, prices vary based on pharmacy or supplier and geographical differences, and are subject to change at any time and at the sole discretion of the pharmacy or durable medical equipment (DME) supplier. If you're asked to pay more than $75 for two sensors, use this copay card¶ to start saving. Show it to your pharmacist each time you pick up your prescription.
Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
‡ Participating pharmacies are subject to change without notice. Product availability may vary by retailer.
¶ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
The Libre 3 systems are covered by the Department of Veterans Affairs for those who qualify1,6.
Please contact your healthcare provider as a prescription is required for the Libre 3 Plus sensor and reader. Your healthcare provider may also be able to provide more information on accessing the Libre 3 system using any applicable benefits and eligibility criteria.
Prescription Criteria6:
- When your healthcare provider prescribes the continuous glucose monitor (CGM), they must confirm and document that you have diabetes and are being treated with daily insulin.
- You will need to know:
- How to use a CGM device.
- About fingerstick testing for calibration, and how to evaluate “high” or “low” blood glucose results or trends based on readings and/or alarms.
- You have followed your healthcare provider's recommendations for glucose testing and medication as directed.
- You agree to ongoing medical appointments with your healthcare provider(s) at least every 6 months.
Therapeutic CGM is provided based on the Veteran’s individual medical needs and is prescribed based upon clinician and patient shared decision making as recommended by the VA/DoD Guidelines of Management of Diabetes Mellitus in Primary Care (2023)6.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
References: 1. Data on file. Abbott Diabetes Care, Inc. 6. Department of Veterans Affairs. VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus: Quick Reference Guide. Accessed September 9, 2026. https://www.healthquality.va.gov/guidelines/CD/diabetes/VADOD-Diabetes-CPG-Quick-Reference-Guide_final_508.pdf (PDF, 724 KB).
The Libre 3 systems are covered by the Department of Defense TRICARE for those who qualify4,5.
Please contact your healthcare provider as a Prior Authorization is required for the Libre 3 Plus sensor and reader.
Prescription Criteria4,5:
- Your healthcare provider has filled out an initial Prior Authorization (expires in 1 year).
- You have been diagnosed with type 1 OR type 2 diabetes.
- One of the following situations applies to you:
- You have been using long-acting (basal) and meal-time (prandial) insulin injections.
- You are receiving insulin infusions continuously (through an insulin pump, for example).
- You have type 2 diabetes and are receiving insulin therapy, and have a history of severe hypoglycemia episodes requiring medical intervention.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
References: 4. Department of Defense Pharmacy and Therapeutics Committee Recommendations from the February 2024 Meeting Information for the Uniform Formulary Beneficiary Advisory Panel. Accessed September 9, 2026. https://health.mil/Reference-Center/Meeting-References/2024/03/27/UF-BAP-Background-Document-April-3-2024-time-zone-edited. 5. Department of Defense Pharmacy and Therapeutics Committee Recommendations from the November 2022 Meeting Information for the Uniform Formulary Beneficiary Advisory Panel. Accessed September 9, 2026. https://www.health.mil/Reference-Center/Meeting-References/2022/12/16/BAP-Background-Document-for-the-Nov-2022-PT-Meeting.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
† Patients must meet Medicare eligibility coverage criteria.
¶ Benefits apply to FreeStyle Libre personal CGM sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
*** Based on pharmacy claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare or fee-for-service Medicaid. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
††† Patients must meet eligibility coverage criteria.
‡‡‡ A history of problematic hypoglycemia requires documentation of at least one of the following: 1) Recurrent level 2 hypoglycemic events (glucose <54mg/dL) that persist despite multiple (2 or more) attempts to adjust medication(s) and/or modify the diabetes treatment plan; or 2) one level 3 hypoglycemic event (glucose <54mg/dL) characterized by altered mental and/or physical state requiring third-party assistance for treatment of hypoglycemia.
§§§ Based on pharmacy claims for the aggregate of patients covered by Managed Medicare using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
References: 1. Data on file. Abbott Diabetes Care, Inc. 2. Local Coverage Determination (LCD) L33822, Glucose Monitors. Accessed September 9, 2026. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822. 3. Memorandum, Updated Guidance on Patient Selection Criteria for Continuous Glucose Monitors (CGM), July 7, 2023. Department of Veterans Affairs. 4. Department of Defense Pharmacy and Therapeutics Committee Recommendations from the February 2024 Meeting Information for the Uniform Formulary Beneficiary Advisory Panel. Accessed September 9, 2026. https://health.mil/Reference-Center/Meeting-References/2024/03/27/UF-BAP-Background-Document-April-3-2024-time-zone-edited. 5. Department of Defense Pharmacy and Therapeutics Committee Recommendations from the November 2022 Meeting Information for the Uniform Formulary Beneficiary Advisory Panel. Accessed September 9, 2026. https://www.health.mil/Reference-Center/Meeting-References/2022/12/16/BAP-Background-Document-for-the-Nov-2022-PT-Meeting. 6. Department of Veterans Affairs. VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus: Quick Reference Guide. Accessed September 9, 2026. https://www.healthquality.va.gov/guidelines/CD/diabetes/VADOD-Diabetes-CPG-Quick-Reference-Guide_final_508.pdf.
ADC-2661756 v15.0